BPC 157
People With Early Metabolic Syndrome or Insulin Resistance Though still under investigation, early research suggests 5-Amino-1MQ may benefit those with pre-diabetes or insulin resistance by enhancing glucose utilization and reducing visceral fat but clinical supervision is essential
Currently, Longevity, Performance & Obesity Capsules are being investigated for their potential role in studies involving metabolic health models, obesity-related signaling, insulin sensitivity pathways, mitochondrial efficiency, and age-associated performance decline
Patients usually need to take it every day for the rest of their lives
PubChem Compound Summary for BPC-157 (CID 9941957): molecular formula, molecular weight, and sequence
This is FDA-approved in special situations with gout